Karimi Mehran, Mirzaei Mohsen, Ahmadieh Mohammad Hossein
Department of Pediatrics, School of Medicine, Shahid Sadoughi University Of Medical Sciences and Health Services, Yazd, Iran.
Iran J Allergy Asthma Immunol. 2006 Jun;5(2):63-7.
Allergic diseases are frequent in children and their prevalence and severity differ in the different regions of the world. A number of studies have been performed to determine the factors which are effective in the incidence of these diseases. One of the drugs that might have a role in incidence or intensity of the symptoms of allergic diseases is Acetaminophen. In our survey conducted with standardized method (International Study of Asthma and Allergies in Childhood), 3000 children 6-7 years old and 3000 teenagers 13-14 years old were questioned regarding asthma, allergic rhinitis and eczema. The prevalence of ever wheezing in the children of 6-7 years old who took acetaminophen in the first year of their life was 11.3%, which is more than other group (Odds Ratio=1.54, 95% Confidence Interval: 1-2.38, P=0.049) and the prevalence of ever wheezing in older age group who have taken acetaminophen at least once in a month was 25.1% which is more than those taken less acetaminophen (OR=1.7, 95%CI=1.43-2.04, P=0.000). Moreover taking more acetaminophen during past 12 months led to more prevalence of night dry coughs and the symptoms of rhinitis in children 6-7 years old and eczema and rhinitis symptoms in the 13-14 years old. Our findings suggest that taking more acetaminophen may be associated with increasing allergic symptoms in children.
过敏性疾病在儿童中很常见,其患病率和严重程度在世界不同地区有所不同。已经进行了多项研究来确定对这些疾病发病率有影响的因素。对乙酰氨基酚可能是在过敏性疾病症状的发生或严重程度方面起作用的药物之一。在我们采用标准化方法(国际儿童哮喘和过敏研究)进行的调查中,对3000名6至7岁的儿童和3000名13至14岁的青少年询问了哮喘、过敏性鼻炎和湿疹的情况。在出生第一年服用对乙酰氨基酚的6至7岁儿童中,曾经喘息的患病率为11.3%,高于其他组(优势比=1.54,95%置信区间:1 - 2.38,P = 0.049),而在每月至少服用一次对乙酰氨基酚的年龄较大组中,曾经喘息的患病率为25.1%,高于服用对乙酰氨基酚较少的组(OR = 1.7,95%CI = 1.43 - 2.04,P = 0.000)。此外,在过去12个月中服用更多对乙酰氨基酚导致6至7岁儿童夜间干咳和鼻炎症状以及13至14岁儿童湿疹和鼻炎症状的患病率更高。我们的研究结果表明,服用更多对乙酰氨基酚可能与儿童过敏症状增加有关。